GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » Other Operating Expense

Renalytix (LSE:RENX) Other Operating Expense : £5.56 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Renalytix Other Operating Expense?

Renalytix's Other Operating Expense for the three months ended in Mar. 2024 was £0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was £5.56 Mil.

Renalytix's quarterly Other Operating Expense increased from Sep. 2023 (£-0.00 Mil) to Dec. 2023 (£5.56 Mil) but then declined from Dec. 2023 (£5.56 Mil) to Mar. 2024 (£0.00 Mil).

Renalytix's annual Other Operating Expense declined from Jun. 2021 (£5.58 Mil) to Jun. 2022 (£-0.09 Mil) but then increased from Jun. 2022 (£-0.09 Mil) to Jun. 2023 (£-0.01 Mil).


Renalytix Other Operating Expense Historical Data

The historical data trend for Renalytix's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Other Operating Expense Chart

Renalytix Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Operating Expense
Get a 7-Day Free Trial - - 5.58 -0.09 -0.01

Renalytix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 5.56 -

Renalytix Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was £5.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renalytix Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Renalytix's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Renalytix (LSE:RENX) Business Description

Traded in Other Exchanges
Address
5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix (LSE:RENX) Headlines

From GuruFocus

Causeway International's Top Five Holdings

By Monica Wolfe Monica Wolfe 08-29-2013

Paul Singer Buys Reed Elesvier

By matsandalex matsandalex 12-14-2012

Investing in Information

By Vanina Egea Vanina Egea 03-06-2014